Thursday, October 30, 2025

Khiron Life “Renews” Buyback Program, Last Program Was A Bust

Khiron Life Sciences (TSXV: KHRN) this morning announced that it is renewing its normal course issuer bid program, which is more commonly referred to as share buybacks. The program is classified as a renewal despite the firms share count expanding multiple times over the last year.

Under the prior program, the company was able to repurchase up to 5.8 million common shares of the issuer. Of this, only 511,500 shares were repurchased, or roughly 0.4% of the outstanding shares of the company, at an average price of $0.41 per share.

Instead, the company has expanded it share count several times over the last year, despite this program reportedly being ongoing. For instance, the company issued 32.2 million units back in November 2020 as part of an oversubscribed $14.5 million bought deal financing. A further 27.4 million units were issued in July 2021 following a $12.3 million bought deal financing.

The latter financing was after the conclusion of the now renewed share buyback program, however it is worth noting.

This latest program will now see up to 5% of the firms outstanding shares repurchased yet again, except this time that figure is good for up to 9.0 million shares. The company has until September 14, 2022 to potentially repurchase these shares under the current program. The program is being facilitated via Scotia Capital.

Khiron Life Sciences last traded at $0.29 on the TSX Venture.


Information for this briefing was found via Sedar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Silver’s Finally Breaking the System | Keith Neumeyer – First Majestic

The Best News for Gold Was the Drop! – Peter Grandich

McEwen Copper: The Los Azules Feasibility Study

Recommended

Silver47 Completes Property-Wide Geochemical, Rock Sampling Program At Adams Plateau, Identifies Numerous Targets

Altamira Gold Identifies Presence Of Second Mineralized Porphyry Body At Cajueiro

Related News

Khiron Life Sciences Receives Authorization For The Sale Of High-CBD Medical Cannabis In Peru

Khiron Life Sciences (TSXV: KHRN) announced this morning that it now has access to yet...

Thursday, July 23, 2020, 08:59:43 AM

Khiron Receives National Strategic Project Status From Colombian Government

This morning Khiron Life Sciences Corp (TSXV: KHRN) announced they received the status of National...

Tuesday, September 22, 2020, 09:43:55 AM

Khiron Receives Authorization For Sale Of High-THC Medical Cannabis

Khiron Life Sciences (TSXV: KHRN) announced this morning that it has received authorization from the...

Wednesday, May 20, 2020, 08:47:31 AM

The Deep Dive Compiles Company Profile on Khiron Life Sciences

The Deep Dive has assembled a company profile for that of Khiron Life Sciences (TSXV:...

Sunday, May 31, 2020, 09:00:00 AM

Khiron Life Sciences To Conduct Share Buybacks

Khiron Life Sciences (TSXV: KHRN) announced this morning that it will be conducting a normal...

Tuesday, February 11, 2020, 09:20:58 AM